2-Deoxy-D-Glucose: A Repurposed Drug for COVID-19 Treatment
Drug Repurposing for Emerging Infectious Diseases and Cancer
; : 479-500, 2023.
Artículo
en Inglés
| Scopus | ID: covidwho-20234185
ABSTRACT
Coronaviruses is a broad group of viruses that has the potential to cause mild or severe respiratory infections. Currently, there is no specific treatment for the treatment of COVID-19. The symptomatic treatment is generally given on case-to-case basis along with basic life supportive measures for management of COVID-19. There is an acute urgency of evaluating the pre-existing drugs to develop a convincing treatment for COVID-19 or at least to reduce its severity. 2-DG being inhibitor of both glycolysis and glycosylation appears as a promising therapeutic option. In the present chapter, the rationale of repurposing of 2-DG as a potential treatment option for the management of COVID-19 has been discussed. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2023.
Texto completo:
Disponible
Colección:
Bases de datos de organismos internacionales
Base de datos:
Scopus
Tipo de estudio:
Estudio experimental
/
Estudio pronóstico
Idioma:
Inglés
Revista:
Drug Repurposing for Emerging Infectious Diseases and Cancer
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS